However, further evaluation of each inclusion criterion for early-onset ANA-positive JIA subgroup indicated that single ANA positivity may achieve similar homogeneity, while lowering the age limit could result in unnecessary patient exclusions without offering substantial gains in uniformity. This evidence concerns the gene BTG3 and juvenile idiopathic arthritis.